Mead Johnson wins US federal bellwether trial on Enfamil NEC claims
A U.S. federal jury sided with Reckitt Benckiser’s Mead Johnson in a test trial over claims Enfamil preterm infant formula caused necrotizing enterocolitis (NEC), a dangerous bowel disease.
By Dietrich Knauth A U.S. federal jury sided with Reckitt Benckiser's Mead Johnson on Monday in a test trial over claims that the company's Enfamil infant formula for preterm babies caused necrotizing enterocolitis (NEC), a dangerous bowel disease. The Illinois jury concluded Enfamil formula did not cause NEC in the bellwether case.